Royal UNIBREW A/S
Share buy-back program
Share buy-back program
COMPANY ANNOUNCEMENT NO 34/2025 - June 23, 2025
On February 25, 2025, Royal Unibrew initiated a share buy-back program, cf. company announcement no. 3/2025 of February 25, 2025.
The program is carried out under Art. 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of April 16, 2014, on market abuse, as amended (the Market Abuse Regulation - MAR) and the Commission Delegated Regulation (EU) No 2016/1052 of March 8, 2016.
The share buy-back program is expected to be realized in the period from February 26, 2025, to August 15, 2025. The total transaction value of the share buy-backs in the period will not exceed DKK 250m.
The following transactions on Nasdaq Copenhagen A/S have been made under the program:
| Number of Shares | Average purchase price DKK | Transaction value, DKK | |
| Accumulated, last announcement | 278,267 | 542.52 | 150,965,987 |
| June 16, 2025 | 4,000 | 548.83 | 2,195,326 |
| June 17, 2025 | 4,000 | 538.54 | 2,154,184 |
| June 18, 2025 | 6,000 | 535.67 | 3,214,021 |
| June 19, 2025 | 4,234 | 535.40 | 2,266,904 |
| June 20, 2025 | 3,500 | 541.46 | 1,895,121 |
| Total accumulated under the program | 300,001 | 542.30 | 162,691,543 |
With the transactions stated above Royal Unibrew owns a total of 433,323 shares, corresponding to 0.9% of the share capital. The total amount of shares in the company is 50,200,000, including treasury shares.
For further information please contact:
Flemming Ole Nielsen (Head of Investor Relations)
E-mail: Flemming.Nielsen@royalunibrew.com
Telephone: +45 25 41 68 04
Encl.
Attachments
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novo Nordisk A/S23.6.2025 20:36:11 CEST | Press release
Novo Nordisk A/S: Ozempic® receives EU recommendation in peripheral arterial disease, cementing the broad benefits of semaglutide for people with type 2 diabetes and comorbidities
PhysicsX23.6.2025 18:38:20 CEST | Press release
PhysicsX Raises $135M Series B to Usher in a New Era of AI-Native Engineering and Manufacturing
Wolters Kluwer N.V.23.6.2025 17:30:00 CEST | Press release
Wolters Kluwer successfully prices €500 million five-year Eurobond
ACI23.6.2025 16:34:07 CEST | Press release
ACI, Council of State refers decision on commissioner appointment back to TAR for full review
Pandora A/S23.6.2025 16:12:07 CEST | Press release
Major shareholder announcement
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom